Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The George and Barbara show

This article was originally published in The Tan Sheet

Executive Summary

"It may interest you to know that George and I have recently started taking Ginkoba," former First Lady Barbara Bush tells the CHPA annual meeting. "It is said there are four good things about getting forgetful as you get older. First, you make new friends every day. Second, every joke you hear is a new one. And you can hide your own Easter eggs. And the fourth one is - well, I forget. So we've turned to Ginkoba for help, and it's given us a keen appreciation for what your industry is all about," she continued. Pharmaton makes the ginkgo biloba supplement. Mrs. Bush was accompanied by her husband, former President George Bush, who discussed fatherhood, life after the White House and the most difficult decision he made as President: sending troops into combat. President Bush also entertained the audience with his best Ross Perot impersonation

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS089575

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel